6Kozakova M, Palombo C, Pratali L, et al. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography [ J ]. Hypertension, 1997,29 ( 2 ) :551-559.
7Frohlich E D. Renin-angiotensin system inhibition improves coronary flow reserve in hypertension[ J]. J Cardiovasc Pharmacol,2001,37 ( Suppll ) : S35-39.
8[1]Chaitman BR.Efficacy and safety of a metabolic modulator drug in chronic stable angina.,review of evidence from clinical trials.J Cardiovasc Pharmacol Ther,2004,9(Suppl.1):S47-S64.
9[3]Harris BM,Nageh T,Marsden JT,et al.Comparison of CardialtroponinT and I and CK-MBfor the detectionof minor myocardial damage during interventional cardiac procedures J.Ann Clin Biochem,2000,37(116):764-769.
10[4]Selvaraj SK,Giri RK,Perelman N,et al.Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor.Blood,2003,102(4):1515-1524.
